These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 17499227

  • 1. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.
    Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH, Tsushima RG, Scholey JW, Khokha R, Penninger JM.
    Cardiovasc Res; 2007 Jul 01; 75(1):29-39. PubMed ID: 17499227
    [Abstract] [Full Text] [Related]

  • 2. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB, Bodiga S, Fan D, Das SK, Wang Z, Wang W, Basu R, Zhong J, Kassiri Z, Oudit GY.
    Hypertension; 2012 Jun 01; 59(6):1195-203. PubMed ID: 22508831
    [Abstract] [Full Text] [Related]

  • 3. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z, Zhong J, Guo D, Basu R, Wang X, Liu PP, Scholey JW, Penninger JM, Oudit GY.
    Circ Heart Fail; 2009 Sep 01; 2(5):446-55. PubMed ID: 19808375
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB, Clarke N, Wang Z, Fan D, Parajuli N, Basu R, Putko B, Kassiri Z, Turner AJ, Oudit GY.
    J Mol Cell Cardiol; 2014 Jan 01; 66():167-76. PubMed ID: 24332999
    [Abstract] [Full Text] [Related]

  • 5. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
    Zhong J, Guo D, Chen CB, Wang W, Schuster M, Loibner H, Penninger JM, Scholey JW, Kassiri Z, Oudit GY.
    Hypertension; 2011 Feb 01; 57(2):314-22. PubMed ID: 21189404
    [Abstract] [Full Text] [Related]

  • 6. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
    Bodiga S, Zhong JC, Wang W, Basu R, Lo J, Liu GC, Guo D, Holland SM, Scholey JW, Penninger JM, Kassiri Z, Oudit GY.
    Cardiovasc Res; 2011 Jul 01; 91(1):151-61. PubMed ID: 21285291
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB, Zhong JC, Fan D, Basu R, Morton JS, Parajuli N, McMurtry MS, Davidge ST, Kassiri Z, Oudit GY.
    Hypertension; 2014 Jul 01; 64(1):157-64. PubMed ID: 24799609
    [Abstract] [Full Text] [Related]

  • 8. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY, Chen LJ, Zhang ZZ, Xu YL, Song B, Xu R, Oudit GY, Gao PJ, Zhu DL, Zhong JC.
    J Transl Med; 2015 Aug 06; 13():255. PubMed ID: 26245758
    [Abstract] [Full Text] [Related]

  • 9. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
    Nakamura K, Koibuchi N, Nishimatsu H, Higashikuni Y, Hirata Y, Kugiyama K, Nagai R, Sata M.
    Hypertens Res; 2008 Oct 06; 31(10):1953-61. PubMed ID: 19015603
    [Abstract] [Full Text] [Related]

  • 10. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ, Shang QH, Jin HY, Song B, Oudit GY, Lu L, Zhou T, Xu YL, Gao PJ, Zhu DL, Penninger JM, Zhong JC.
    J Transl Med; 2013 Sep 25; 11():229. PubMed ID: 24067190
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY.
    Circulation; 2010 Aug 17; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [Abstract] [Full Text] [Related]

  • 12. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis.
    Patel VB, Bodiga S, Basu R, Das SK, Wang W, Wang Z, Lo J, Grant MB, Zhong J, Kassiri Z, Oudit GY.
    Circ Res; 2012 May 11; 110(10):1322-35. PubMed ID: 22474255
    [Abstract] [Full Text] [Related]

  • 13. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
    Hayashi N, Yamamoto K, Ohishi M, Tatara Y, Takeya Y, Shiota A, Oguro R, Iwamoto Y, Takeda M, Rakugi H.
    Hypertens Res; 2010 Nov 11; 33(11):1182-5. PubMed ID: 20703229
    [Abstract] [Full Text] [Related]

  • 14. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
    Ohshima K, Mogi M, Nakaoka H, Iwanami J, Min LJ, Kanno H, Tsukuda K, Chisaka T, Bai HY, Wang XL, Ogimoto A, Higaki J, Horiuchi M.
    Hypertension; 2014 Mar 11; 63(3):e53-9. PubMed ID: 24379178
    [Abstract] [Full Text] [Related]

  • 15. Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy.
    Jing L, Li WM, Zhou LJ, Li S, Kou JJ, Song J.
    Alcohol Clin Exp Res; 2008 Nov 11; 32(11):1999-2007. PubMed ID: 18783396
    [Abstract] [Full Text] [Related]

  • 16. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
    Jin HY, Song B, Oudit GY, Davidge ST, Yu HM, Jiang YY, Gao PJ, Zhu DL, Ning G, Kassiri Z, Penninger JM, Zhong JC.
    PLoS One; 2012 Nov 11; 7(6):e38502. PubMed ID: 22693641
    [Abstract] [Full Text] [Related]

  • 17. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
    Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M, Tatara Y, Shiota A, Sugano S, Takeda S, Rakugi H, Ogihara T.
    Hypertension; 2006 Apr 11; 47(4):718-26. PubMed ID: 16505206
    [Abstract] [Full Text] [Related]

  • 18. Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.
    Yang XH, Wang YH, Wang JJ, Liu YC, Deng W, Qin C, Gao JL, Zhang LY.
    Peptides; 2012 Jul 11; 36(1):60-70. PubMed ID: 22580272
    [Abstract] [Full Text] [Related]

  • 19. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
    Pernomian L, Pernomian L, Baraldi Araújo Restini C.
    Vasa; 2014 Nov 11; 43(6):404-14. PubMed ID: 25339158
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
    Su Z, Zimpelmann J, Burns KD.
    Kidney Int; 2006 Jun 11; 69(12):2212-8. PubMed ID: 16672906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.